The GLP-1 Revolution — Everyone And Their Moms Are On GLP-1s
The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...
Medpage Today on MSN1d
GLP-1 Receptor Agonists for Diabetes Tied to Slightly Lower Depression Risk
Among 13,711 matched pairs, GLP-1 receptor agonist users had a 10% lower risk for depression compared with DPP-4 inhibitor ...
Medscape1d
GLP-1 Drugs Cut Glaucoma Risk in Nondiabetic Obesity
GLP-1 RAs show protective effects against primary open-angle glaucoma and ocular hypertension, surpassing alternative weight ...
Medical News Today3d
GLP-1 drugs may aid brain health, but do they bring other risks?
Some studies link GLP-1 drugs for diabetes with neuroprotective benefits but others say that some of these drugs may increase ...
Study finds GLP-1 receptor agonists target fat over muscle for weight loss
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class ...
Depression risk lower with GLP-1 receptor agonists versus DPP-4 inhibitors in seniors, study reveals
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
Science Daily1d
Genetic evidence that diabetes drug GLP-1 receptor agonists achieve weight loss primarily by reducing fat mass more than muscle
Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...
FoodNavigator1d
Is this GLP-1.2? New generation of weight-loss drugs moving in
Glucagon-like peptite-1 (GLP-1) receptor agonists, such as Wegovy and Ozempic, have taken the food industry by storm. With ...
GLP-1 receptor agonists could hold promise for opioid use disorder treatment
Treatment for OUD is currently dominated by opioid agonist therapies that are highly regulated due to their liability for ...
Hosted on MSN1d
Depression Risk Lower With GLP-1 Receptor Agonists Versus DPP-4 Inhibitors in Seniors
For older adults with type 2 diabetes (T2D), use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with ...
Yes, GLP-1 Medications Really Do Reduce Alcohol Cravings, Per A New Study
It’s possible that GLP-1s may be useful for a range of substance use disorders, including opioid use disorder and nicotine ...
Monthly Prescribing Reference6d
Many With Overweight, Obesity Discontinue GLP-1 Receptor Agonists Within One Year
HealthDay News — Many patients with overweight or obesity discontinue glucagon-like peptide-1 (GLP-1) receptor agonist therapy within one year, with higher discontinuation rates seen for those without ...